ASND
Featured PickAscendis Pharma A/S
Real picks. Real tracking. We bet on one stock daily and show you exactly how it plays out.
AI Confidence Score
82
Entry Price
$222.08
Current Price
$330.34
Total Return
+0.00%
vs SPY
+0.00%
As of Close 2026-04-28
Executive Summary
Ascendis Pharma (ASND) is triggering a powerful momentum breakout following the strategic redemption of its $575 million convertible notes, effectively removing a massive debt overhang and signaling robust financial health. This aggressive capital structure optimization has ignited a massive wave of institutional accumulation, perfectly aligning with the current RISK_ON market regime that heavily favors high-beta momentum plays. With capital rotating aggressively into strength despite macro noise, ASND's decisive price action demonstrates the exact type of corporate fundamental strength the market is rewarding.
Technical Context
Setup
The stock is surging on explosive volume that is 2.9x its 20-day average, leaving it with significant room to run as it sits just 11.1% below its 52-week high.
Invalidation (Stop)
The bullish thesis remains intact as long as the stock maintains price structure above the critical $220.48 support level.
Runner-ups
Recent Performance History
58 Total Picks • 53% Win Rate (7d)
| Date | Ticker | Entry | Last | Gain/Loss | 7d | 30d | 60d |
|---|---|---|---|---|---|---|---|
| 2026-04-27 | CVLG | $34.95 | $34.99 | +0.11% | N/A | N/A | N/A |
| 2026-04-24 | FOLD | $14.49 | $14.49 | +0.00% | N/A | N/A | N/A |
| 2026-04-23 | WAFD | $35.42 | $35.58 | +0.45% | N/A | N/A | N/A |
| 2026-04-22 | ASND | $231.05 | $222.08 | -3.88% | N/A | N/A | N/A |
| 2026-04-21 | DBRG | $15.61 | $15.57 | -0.26% | -0.26% | N/A | N/A |
| 2026-04-20 | WAFD | $35.20 | $35.58 | +1.08% | +0.85% | N/A | N/A |
| 2026-04-17 | WAFD | $35.24 | $35.58 | +0.96% | -0.11% | N/A | N/A |
| 2026-04-16 | WABC | $53.71 | $55.06 | +2.51% | +1.75% | N/A | N/A |
| 2026-04-15 | ASND | $241.71 | $222.08 | -8.12% | -4.41% | N/A | N/A |
| 2026-04-13 | ASND | $248.55 | $222.08 | -10.65% | -1.28% | N/A | N/A |
Schema v1.0 | Pipeline v1.2.0